Join Drs Forest Arnold and Brittanie West as they discuss their personal experience preventing and managing RSV in adults in their Appalachian communities.

Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/998284. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Respiratory Syncytial Virus Infection https://emedicine.medscape.com/article/971488-overview

RSV in Rural Communities: Lessons From Appalachia https://www.medscape.com/viewarticle/985982

CDC RSV Surveillance and Research https://www.cdc.gov/rsv/research/index.html

American Hospital Association Rural Report rural-report-2019.pdf (aha.org) https://www.aha.org/system/files/2019-02/rural-report-2019.pdf

Physician Learning Preferences physician-learning-report-2022.pdf (doximity.com) https://press.doximity.com/reports/physician-learning-report-2022.pdf

Do You Spend More Time Searching for Medical Information Than the Average American? https://swnsdigital.com/us/2020/11/do-you-spend-more-time-searching-for-medical-information-than-the-average-american/

One Assay to Test Them All: Multiplex Assays for Expansion of Respiratory Virus Surveillance https://pubmed.ncbi.nlm.nih.gov/37168265/

Respiratory Syncytial Virus Hospitalization Surveillance Network (RSV-NET) https://www.cdc.gov/rsv/research/rsv-net/index.html

RSVVaxView https://www.cdc.gov/vaccines/imz-managers/coverage/rsvvaxview/index.html

REVIRAL 1 https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/reviral-1/

A Randomized, Placebo-Controlled, Respiratory Syncytial Virus Human Challenge Study of the Antiviral Efficacy, Safety, and Pharmacokinetics of RV521, an Inhibitor of the RSV-F Protein https://pubmed.ncbi.nlm.nih.gov/31712214/